NCT06815874

Brief Summary

RUSE is a retrospective data-based study designed to assess the frequency, characteristics and phenotype of documented recurrences of thromboembolic venous disease in atypical locations.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 4, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 10, 2025

Completed
18 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2025

Completed
Last Updated

February 10, 2025

Status Verified

November 1, 2024

Enrollment Period

3 months

First QC Date

February 4, 2025

Last Update Submit

February 4, 2025

Conditions

Venous Thromboembolism

Outcome Measures

Primary Outcomes (1)

  • Documented recurrence after previous VTE in atypical localisations

    All forms of VTE of typical (DVT and PE) and atypical location, muscular venous thrombosis and documented superficial venous thrombosis

    01/01/2005 to 01/11/2024

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Any patient with documented atypical localisation of VTE

You may qualify if:

  • All patients over 18,
  • Affiliated to "sécurité sociale"
  • Having at least one episode of atypical localisation of VTE at Brest University Hospital

You may not qualify if:

  • Patients under legal protection
  • Minors
  • Refusal to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chu Brest

Brest, France

Location

MeSH Terms

Conditions

Venous Thromboembolism

Condition Hierarchy (Ancestors)

ThromboembolismEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 4, 2025

First Posted

February 10, 2025

Study Start

December 1, 2024

Primary Completion

February 28, 2025

Study Completion

February 28, 2025

Last Updated

February 10, 2025

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will share

All collected data that underlie results in a publication

Shared Documents
STUDY PROTOCOL
Time Frame
Data will be available beginning three years and ending fifteen years following the final study report completion
Access Criteria
Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement

Locations

FR(1)